Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Sanofi's Xenpozyme Is First Drug Approved For Rare Genetic Disease ASMD
Aug 31 2022
•
By
Jessica Merrill
FDA approved the first drug for ASMD, a rare genetic disease. • Source: Shutterstock
More from New Products
More from Scrip